Krystallinsk L-argininsalt af (R)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3- yl)eddikesyre til anvendelse ved S1P1-receptor-associerede lidelser

The present invention relates to, inter alia, a novel crystalline free-plate habit or morphology, processes for preparing the crystalline free-plate habit, and uses of the crystalline free-plate habit of the L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MA, You-An, CASTRO, Ryan O, SELVEY, Lee Alani, SHAKYA, Sagar Raj, HADD, Mark A, RUETER, Jaimie Karyn, MONTALBAN, Antonio Garrido, CARLOS, Marlon, BLACKBURN, Anthony C
Format:	Patent
Sprache:	dan
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	MA, You-An CASTRO, Ryan O SELVEY, Lee Alani SHAKYA, Sagar Raj HADD, Mark A RUETER, Jaimie Karyn MONTALBAN, Antonio Garrido CARLOS, Marlon BLACKBURN, Anthony C
description	The present invention relates to, inter alia, a novel crystalline free-plate habit or morphology, processes for preparing the crystalline free-plate habit, and uses of the crystalline free-plate habit of the L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid (Compound 1) in the treatment of S1P1 receptor-associated disorders, for example, diseases and disorders mediated by lymphocytes, transplant rejection, autoimmune diseases and disorders, inflammatory diseases and disorders (e.g., acute and chronic inflammatory conditions), cancer, and conditions characterized by an underlying defect in the vascular integrity or that are associated with angiogenesis such as may be pathologic (e.g., as may occur in inflammation, tumor development, and atherosclerosis).
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK3310760TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK3310760TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK3310760TT33</originalsourceid><addsrcrecordid>eNqNjE1OwzAQRrNhgQp3MLtEykhNXdED8COkskCQHULV1J60Vgc7Gg8V5nCcjYAQa1bfW7z3nVafaylZkTnEfDD3gLILcWJkNTiY-rGBBdQrqJfgiuM0UtTCYKFWCQO_JXkl3RduthQ_Cqf30kDXLlrbLkFJBffFS_pL8Xn7EqJP3w9mqsj7cKBchIwGNhiPFD1xJnMkb566hw6EHI2aBDDn5AIJeTIcfiw5q04GnOD8d2fVxe1Nf3UHNKYN5REdRdLN9drabr66nPe9tf9xvgDBdV5i</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Krystallinsk L-argininsalt af (R)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3- yl)eddikesyre til anvendelse ved S1P1-receptor-associerede lidelser</title><source>esp@cenet</source><creator>MA, You-An ; CASTRO, Ryan O ; SELVEY, Lee Alani ; SHAKYA, Sagar Raj ; HADD, Mark A ; RUETER, Jaimie Karyn ; MONTALBAN, Antonio Garrido ; CARLOS, Marlon ; BLACKBURN, Anthony C</creator><creatorcontrib>MA, You-An ; CASTRO, Ryan O ; SELVEY, Lee Alani ; SHAKYA, Sagar Raj ; HADD, Mark A ; RUETER, Jaimie Karyn ; MONTALBAN, Antonio Garrido ; CARLOS, Marlon ; BLACKBURN, Anthony C</creatorcontrib><description>The present invention relates to, inter alia, a novel crystalline free-plate habit or morphology, processes for preparing the crystalline free-plate habit, and uses of the crystalline free-plate habit of the L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid (Compound 1) in the treatment of S1P1 receptor-associated disorders, for example, diseases and disorders mediated by lymphocytes, transplant rejection, autoimmune diseases and disorders, inflammatory diseases and disorders (e.g., acute and chronic inflammatory conditions), cancer, and conditions characterized by an underlying defect in the vascular integrity or that are associated with angiogenesis such as may be pathologic (e.g., as may occur in inflammation, tumor development, and atherosclerosis).</description><language>dan</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221024&DB=EPODOC&CC=DK&NR=3310760T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221024&DB=EPODOC&CC=DK&NR=3310760T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MA, You-An</creatorcontrib><creatorcontrib>CASTRO, Ryan O</creatorcontrib><creatorcontrib>SELVEY, Lee Alani</creatorcontrib><creatorcontrib>SHAKYA, Sagar Raj</creatorcontrib><creatorcontrib>HADD, Mark A</creatorcontrib><creatorcontrib>RUETER, Jaimie Karyn</creatorcontrib><creatorcontrib>MONTALBAN, Antonio Garrido</creatorcontrib><creatorcontrib>CARLOS, Marlon</creatorcontrib><creatorcontrib>BLACKBURN, Anthony C</creatorcontrib><title>Krystallinsk L-argininsalt af (R)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3- yl)eddikesyre til anvendelse ved S1P1-receptor-associerede lidelser</title><description>The present invention relates to, inter alia, a novel crystalline free-plate habit or morphology, processes for preparing the crystalline free-plate habit, and uses of the crystalline free-plate habit of the L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid (Compound 1) in the treatment of S1P1 receptor-associated disorders, for example, diseases and disorders mediated by lymphocytes, transplant rejection, autoimmune diseases and disorders, inflammatory diseases and disorders (e.g., acute and chronic inflammatory conditions), cancer, and conditions characterized by an underlying defect in the vascular integrity or that are associated with angiogenesis such as may be pathologic (e.g., as may occur in inflammation, tumor development, and atherosclerosis).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjE1OwzAQRrNhgQp3MLtEykhNXdED8COkskCQHULV1J60Vgc7Gg8V5nCcjYAQa1bfW7z3nVafaylZkTnEfDD3gLILcWJkNTiY-rGBBdQrqJfgiuM0UtTCYKFWCQO_JXkl3RduthQ_Cqf30kDXLlrbLkFJBffFS_pL8Xn7EqJP3w9mqsj7cKBchIwGNhiPFD1xJnMkb566hw6EHI2aBDDn5AIJeTIcfiw5q04GnOD8d2fVxe1Nf3UHNKYN5REdRdLN9drabr66nPe9tf9xvgDBdV5i</recordid><startdate>20221024</startdate><enddate>20221024</enddate><creator>MA, You-An</creator><creator>CASTRO, Ryan O</creator><creator>SELVEY, Lee Alani</creator><creator>SHAKYA, Sagar Raj</creator><creator>HADD, Mark A</creator><creator>RUETER, Jaimie Karyn</creator><creator>MONTALBAN, Antonio Garrido</creator><creator>CARLOS, Marlon</creator><creator>BLACKBURN, Anthony C</creator><scope>EVB</scope></search><sort><creationdate>20221024</creationdate><title>Krystallinsk L-argininsalt af (R)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3- yl)eddikesyre til anvendelse ved S1P1-receptor-associerede lidelser</title><author>MA, You-An ; CASTRO, Ryan O ; SELVEY, Lee Alani ; SHAKYA, Sagar Raj ; HADD, Mark A ; RUETER, Jaimie Karyn ; MONTALBAN, Antonio Garrido ; CARLOS, Marlon ; BLACKBURN, Anthony C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK3310760TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MA, You-An</creatorcontrib><creatorcontrib>CASTRO, Ryan O</creatorcontrib><creatorcontrib>SELVEY, Lee Alani</creatorcontrib><creatorcontrib>SHAKYA, Sagar Raj</creatorcontrib><creatorcontrib>HADD, Mark A</creatorcontrib><creatorcontrib>RUETER, Jaimie Karyn</creatorcontrib><creatorcontrib>MONTALBAN, Antonio Garrido</creatorcontrib><creatorcontrib>CARLOS, Marlon</creatorcontrib><creatorcontrib>BLACKBURN, Anthony C</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MA, You-An</au><au>CASTRO, Ryan O</au><au>SELVEY, Lee Alani</au><au>SHAKYA, Sagar Raj</au><au>HADD, Mark A</au><au>RUETER, Jaimie Karyn</au><au>MONTALBAN, Antonio Garrido</au><au>CARLOS, Marlon</au><au>BLACKBURN, Anthony C</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Krystallinsk L-argininsalt af (R)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3- yl)eddikesyre til anvendelse ved S1P1-receptor-associerede lidelser</title><date>2022-10-24</date><risdate>2022</risdate><abstract>The present invention relates to, inter alia, a novel crystalline free-plate habit or morphology, processes for preparing the crystalline free-plate habit, and uses of the crystalline free-plate habit of the L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid (Compound 1) in the treatment of S1P1 receptor-associated disorders, for example, diseases and disorders mediated by lymphocytes, transplant rejection, autoimmune diseases and disorders, inflammatory diseases and disorders (e.g., acute and chronic inflammatory conditions), cancer, and conditions characterized by an underlying defect in the vascular integrity or that are associated with angiogenesis such as may be pathologic (e.g., as may occur in inflammation, tumor development, and atherosclerosis).</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	dan
recordid	cdi_epo_espacenet_DK3310760TT3
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	Krystallinsk L-argininsalt af (R)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3- yl)eddikesyre til anvendelse ved S1P1-receptor-associerede lidelser
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T17%3A43%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MA,%20You-An&rft.date=2022-10-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK3310760TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true